ENDOGENOUS RETROVIRUS POLYPEPTIDES LINKED TO ONCOGENIC TRANSFORMATION
    2.
    发明申请
    ENDOGENOUS RETROVIRUS POLYPEPTIDES LINKED TO ONCOGENIC TRANSFORMATION 审中-公开
    与内源性转化相关的内源性逆转录酶多肽

    公开(公告)号:US20140135384A1

    公开(公告)日:2014-05-15

    申请号:US14156167

    申请日:2014-01-15

    IPC分类号: C07K14/005

    摘要: HERV-K human endogenous retroviruses show up-regulated expression in tumors. In particular, splicing events in the env region generate a series of transcripts which utilize the +2 reading frame, relative to the env reading frame. The proteins show activity typical of transcriptional regulators, and they also have oncogenic potential. Two related proteins, PCAP2 and PCAP3, are strongly associated with breast cancer and prostate cancer, respectively. PCAP4 stimulates cell division. These proteins can be used in cancer diagnosis and therapy, and are also drug targets e.g. for adjuvant therapy. The identification of these splice products is remarkable because full sequence information has been available for HERV-K viruses since 1986.

    摘要翻译: HERV-K人内源性逆转录病毒在肿瘤中表达上调。 特别地,env区域中的拼接事件产生一系列相对于env阅读框使用+2阅读框的抄本。 蛋白质表现出转录调节因子的典型活性,并且具有致癌潜力。 两种相关蛋白,PCAP2和PCAP3分别与乳腺癌和前列腺癌密切相关。 PCAP4刺激细胞分裂。 这些蛋白质可用于癌症诊断和治疗,也是药物靶标。 用于辅助治疗。 鉴于这些拼接产品是非常显着的,因为自1986年以来,全序列信息已经可用于HERV-K病毒。

    Norovirus and sapovirus antigens
    3.
    发明授权
    Norovirus and sapovirus antigens 有权
    诺如病毒和滑鼠病毒抗原

    公开(公告)号:US08124104B2

    公开(公告)日:2012-02-28

    申请号:US12383420

    申请日:2009-03-24

    摘要: Immunogenic compositions that elicit immune responses against Norovirus and Sapovirus antigens are described. In particular, the invention relates to polynucleotides encoding one or more capsid proteins or other immunogenic viral polypeptides from one or more strains of Norovirus and/or Sapovirus, coexpression of such immunogenic viral polypeptides with adjuvants, and methods of using the polynucleotides in applications including immunization and production of immunogenic viral polypeptides and viral-like particles (VLPs). Methods for producing Norovirus- or Sapovirus-derived multiple epitope fusion antigens or polyproteins and immunogenic compositions comprising one or more immunogenic polypeptides, polynucleotides, VLPs, and/or adjuvants are also described. The immunogenic compositions of the invention may also contain antigens other than Norovirus or Sapovirus antigens, including antigens that can be used in immunization against pathogens that cause diarrheal diseases, such as antigens derived from rotavirus.

    摘要翻译: 描述了引起针对诺如病毒和曙红病毒抗原的免疫应答的免疫原性组合物。 特别地,本发明涉及编码来自一种或多种诺如病毒和/或札幌病毒株的一种或多种衣壳蛋白或其它免疫原性病毒多肽的多核苷酸,这种免疫原性病毒多肽与佐剂的共表达,以及在包括免疫的应用中使用多核苷酸的方法 以及产生免疫原性病毒多肽和病毒样颗粒(VLP)。 还描述了用于生产包含一种或多种免疫原性多肽,多核苷酸,VLP和/或佐剂的诺如病毒或札幌病毒衍生的多表位融合抗原或多蛋白的免疫原性组合物的方法。 本发明的免疫原性组合物还可以含有除诺如病毒或札幌病毒抗原以外的抗原,包括可用于免疫引起腹泻疾病的病原体的抗原,例如来源于轮状病毒的抗原。

    Chimeric alphavirus replicon particles
    8.
    发明授权
    Chimeric alphavirus replicon particles 有权
    嵌合甲病毒复制子颗粒

    公开(公告)号:US08158418B2

    公开(公告)日:2012-04-17

    申请号:US12372295

    申请日:2009-02-17

    IPC分类号: C12N5/10 C12N15/86 C12N15/64

    摘要: Chimeric alphaviruses and alphavirus replicon particles are provided, including methods of making and using same. Specifically, alphavirus particles are provided having nucleic acid molecules derived from one or more alphaviruses and structural proteins (capsid and/or envelope) from at least two or more alphaviruses. Methods of making, using, and therapeutic preparations containing the chimeric alphavirus particle, are disclosed.

    摘要翻译: 提供嵌合甲病毒和甲病毒复制子颗粒,包括制备和使用它们的方法。 具体地,提供具有源自一种或多种来自至少两种或更多种甲病毒属的一种或多种甲病毒和结构蛋白(衣壳和/或包膜)的核酸分子的甲病毒颗粒。 公开了制备,使用和含有嵌合甲病毒颗粒的治疗制剂的方法。